Page last updated: 2024-10-31

mianserin and Disease, Pulmonary

mianserin has been researched along with Disease, Pulmonary in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hohlfeld, SK1
Günthard, HF1
Zeitz, J1
Locher, P1
Bachli, E1
Brooks, AM1

Other Studies

2 other studies available for mianserin and Disease, Pulmonary

ArticleYear
Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.
    BMJ case reports, 2012, Jun-28, Volume: 2012

    Topics: Adrenergic alpha-Antagonists; Adult; DNA, Viral; Fatal Outcome; Humans; JC Virus; Leukoencephalopath

2012
Pulmonary reaction to mianserin (Tolvon)
    The Medical journal of Australia, 1980, Aug-23, Volume: 2, Issue:4

    Topics: Adult; Dibenzazepines; Humans; Lung Diseases; Male; Mianserin

1980